ロード中...
Subcutaneous abatacept for the treatment of rheumatoid arthritis
The efficacy, safety and tolerability of i.v. abatacept are well established in patients with active RA. A s.c. abatacept formulation is now available in some countries. Here, we review clinical data for s.c. abatacept. Six trials are presented (Phase II dose-finding study, ACQUIRE, ALLOW, ACCOMPANY...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3651617/ https://ncbi.nlm.nih.gov/pubmed/23463804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|